{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:32:51Z","timestamp":1786357971808,"version":"build-2736575974"},"reference-count":44,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Central Hospital of Dalian University of Technology \u2018Climbing Plan\u2019","award":["2023ZZ007"],"award-info":[{"award-number":["2023ZZ007"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Diabetic cardiomyopathy (DCM) is a cardiac condition characterized by various structural and functional abnormalities that are associated with diabetes mellitus. Its development involves multiple factors, among which endothelial dysfunction plays a significant role. To fully describe the relationship between DCM and endothelial dysfunction, we conducted a literature search across several databases, including PubMed, Web of Science, and EMBASE. Our review of DCM research focused on understanding its mechanisms, exploring the methods used to diagnose it, and potential treatment options. Although researchers have made significant progress in DCM diagnosis and treatment in recent years, considerable challenges persist as well. Artificial intelligence (AI)-based multimodal approaches may provide new opportunities for cardiovascular risk stratification and early DCM screening, but DCM-specific models still require external validation before clinical implementation. Regarding treatment options, emerging evidence suggests potential benefits of medications that enhance mitochondrial function and antioxidant properties, as well as anti-inflammatory therapies and lifestyle modifications. Future research should focus on combining different relevant data types, such as genetic and molecular information, to improve the AI tools utilized in medical environments. This study aims to identify novel markers for diagnosing DCM and to devise tailored treatment approaches. These advancements have the potential to improve the prognosis of DCM patients and enhance the identification and management of this condition.<\/jats:p>","DOI":"10.3390\/jcdd13080377","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:24:53Z","timestamp":1786353893000},"page":"377","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in Comprehending Endothelial Dysfunction and Diabetic Cardiomyopathy: From Molecular Mechanisms to Clinical Applications"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-764X","authenticated-orcid":false,"given":"Shengying","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian 116033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Central Hospital of Dalian University of Technology, Dalian 116033, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-0025","authenticated-orcid":false,"given":"Zuowei","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Chengdu Fifth People\u2019s Hospital Affiliated to Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China"},{"name":"Geriatric Diseases Institute of Chengdu, Chengdu 611137, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13098-025-01986-0","article-title":"Diabetic cardiomyopathy: A comprehensive review of diagnosis, management, and future directions","volume":"17","author":"Balakrishnan","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/ejhf.3347","article-title":"Diabetic myocardial disorder. a clinical consensus statement of the heart failure association of the ESC and the ESC working group on myocardial & pericardial diseases","volume":"26","author":"Paulus","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_3","first-page":"1718\u20131727, 1727a\u20131727c","article-title":"Clinical diabetic cardiomyopathy: A two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Paulus","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yang, D., Wang, M., Zhang, C., and Wang, Y. (2024). Endothelial dysfunction in vascular complications of diabetes: A comprehensive review of mechanisms and implications. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1359255"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, M., Li, Y., Li, S., and Lv, J. (2022). Endothelial dysfunction and diabetic cardiomyopathy. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.851941"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Allbritton-King, J.D., and Garc\u00eda-Cardena, G. (2023). Endothelial cell dysfunction in cardiac disease: Driver or consequence?. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1278166"},{"key":"ref_10","first-page":"e110771","article-title":"The gluco-vascular injury axis in diabetic cardiovascular dysfunction: A narrative review","volume":"18","author":"Omair","year":"2026","journal-title":"Cureus"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00018-025-05944-x","article-title":"Circular RNAs and endothelial dysfunction: Mechanistic crosstalk and emerging therapeutic perspectives","volume":"83","author":"Din","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/ars.2023.0524","article-title":"Oxidative stress, endothelial dysfunction, and N-Acetylcysteine in type 2 diabetes mellitus","volume":"40","author":"Li","year":"2024","journal-title":"Antioxid. Redox Signal."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Capece, U., Nilo, D., Morciano, C., Nilo, R., Spiezia, S., Sircana, M.C., Russo, V., Perrone, M.A., Bonfrate, L., and Acierno, C. (2026). Oxidative stress in diabetic cardiomyopathy: Molecular mechanisms and emerging therapeutic targets. Biomolecules, 16.","DOI":"10.3390\/biom16030470"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Scioli, M.G., Storti, G., D\u2019Amico, F., Rodr\u00edguez Guzm\u00e1n, R., Centofanti, F., Doldo, E., C\u00e9spedes Miranda, E.M., and Orlandi, A. (2020). Oxidative stress and new pathogenetic mechanisms in endothelial dysfunction: Potential diagnostic biomarkers and therapeutic targets. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061995"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Liu, R., Liu, W., Dong, L., Ma, S., and Xu, B. (2026). Targeting NF-\u03baB signaling with natural products: A promising therapeutic strategy for cardiovascular diseases. Biomolecules, 16.","DOI":"10.3390\/biom16040491"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cbin.12189","article-title":"The PI3K\/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets","volume":"48","author":"Taheri","year":"2024","journal-title":"Cell Biol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kant, S., and Feng, J. (2025). Protein kinase C and endothelial dysfunction in select vascular diseases. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1618343"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"45417","DOI":"10.31083\/RCM45417","article-title":"Endothelin as a treatment target in cardiovascular diseases: A recent step forward","volume":"26","author":"Cole","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced glycation end products and diabetes mellitus: Mechanisms and perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s40001-023-01431-w","article-title":"Role of advanced glycation end products in diabetic vascular injury: Molecular mechanisms and therapeutic perspectives","volume":"28","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tokuyama, T., and Yanagi, S. (2023). Role of mitochondrial dynamics in heart diseases. Genes, 14.","DOI":"10.3390\/genes14101876"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-025-08236-1","article-title":"The role of mitochondrial-associated endoplasmic reticulum membranes (MAMs) in diabetic microvascular complications: A review","volume":"17","author":"Wang","year":"2026","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.33594\/000000772","article-title":"Dapagliflozin, an SGLT2 inhibitor, improves endothelial cell energy metabolism through enhanced mitochondrial respiration","volume":"59","author":"Walczak","year":"2025","journal-title":"Cell Physiol. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jphs.2023.08.009","article-title":"Compensatory role of neuregulin-1 in diabetic cardiomyopathy","volume":"153","author":"Mikami","year":"2023","journal-title":"J. Pharmacol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Li, S., Wang, M., Ma, J., Pang, X., Yuan, J., Pan, Y., Fu, Y., and Laher, I. (2022). MOTS-c and exercise restore cardiac function by activating of NRG1-ErbB signaling in diabetic rats. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.812032"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ding, X., Bai, G., Liu, X., Dong, Y., Chai, Y., Han, B., Meng, X., and Lei, H. (2026). Circulating exosomal miR-550a-5p\/miR-665 identify coronary microvascular dysfunction and drive endothelial-myocyte crosstalk in type 2 diabetes. Front. Cell Dev. Biol., 14.","DOI":"10.3389\/fcell.2026.1744708"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gad, M.S., Habib, S., and Elmasry, K. (2026). Extracellular Vesicles and Diabetes Research: Current Status and Future Promise. Biomolecules, 16.","DOI":"10.3390\/biom16060909"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cai, G., Zhang, X., Jiao, J., Du, W., and Yan, M. (2025). Targeting the cGAS-STING pathway to modulate immune inflammation in diabetes and cardiovascular complications: Mechanisms and therapeutic insights. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47090750"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Rani, S., Gillani, S.A., Naseer, R., Khalid, M., Fatima, A., Akram, M.B., and Dilshad, A. (2026). Immunometabolism in cardiovascular disease: Linking metabolic reprogramming to inflammation, atherothrombosis, and clinical outcomes. Cardiol. Rev., 8.","DOI":"10.1097\/CRD.0000000000001391"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"H448","DOI":"10.1152\/ajpheart.00287.2018","article-title":"Cellular senescence links aging and diabetes in cardiovascular disease","volume":"315","author":"Shakeri","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/febs.16351","article-title":"Therapeutic opportunities for senolysis in cardiovascular disease","volume":"290","author":"Sweeney","year":"2023","journal-title":"FEBS J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-025-03068-x","article-title":"Insulin resistance and coronary microvascular dysfunction: A complex interplay","volume":"25","author":"Magistri","year":"2026","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rodriguez-Calvo, R., Granado-Casas, M., Perez-Montes, O.A., Julian, M.T., Domingo, M., Codina, P., Santiago-Vacas, E., Cediel, G., Julve, J., and Rossell, J. (2023). Fatty acid binding proteins 3 and 4 predict both all-cause and cardiovascular mortality in subjects with chronic heart failure and type 2 diabetes mellitus. Antioxidants, 12.","DOI":"10.3390\/antiox12030645"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/ejhf.3287","article-title":"Insulin-like growth factor binding protein-7 in heart failure: The challenge of moving from risk prediction to a biomarker-guided management","volume":"26","author":"Panichella","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107285","DOI":"10.1016\/j.phrs.2024.107285","article-title":"The role of matrix metalloproteinase-9 in cardiac remodeling and dysfunction and as a possible blood biomarker in heart failure","volume":"206","author":"Rodrigues","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s11010-023-04909-7","article-title":"The study of the mechanism of non-coding RNA regulation of programmed cell death in diabetic cardiomyopathy","volume":"479","author":"Zhang","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41420-023-01553-4","article-title":"Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions","volume":"9","author":"Huo","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Yang, W., Jiang, M., Zhang, H., Zhou, D., Wang, Y., Zhu, L., Tian, Z., Yin, G., Zhang, Q., and Sirajuddin, A. (2025). Risk stratification and outcomes in diabetes mellitus patients with preserved ejection fraction: A cardiac MRI study. BMC Med., 23.","DOI":"10.1186\/s12916-025-04354-x"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.15850","article-title":"Amelioration of endothelial dysfunction by sodium glucose co-transporter 2 inhibitors: Pieces of the puzzle explaining their cardiovascular protection","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Battistoni1, A., Piras, L., Tartaglia1, N., Carrano, F.M., De Vitis, C., and Barbato, E. (2025). Glucagon-like peptide-1 receptor agonists and the endothelium: Molecular and clinical insights into cardiovascular protection. Front. Med., 12.","DOI":"10.3389\/fmed.2025.1669685"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/HYPERTENSIONAHA.109.130351","article-title":"Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy","volume":"54","author":"Graham","year":"2009","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial atioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/bph.12461","article-title":"First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics","volume":"171","author":"Szeto","year":"2014","journal-title":"Br. J. Pharmacol."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/377\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:03:14Z","timestamp":1786356194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080377"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080377","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}